Section
Pipeline
Late-stage drugs with significant commercial implications
PipelineFierceBiotech ↗
As Eli Lilly looks to hold its lead in the lucrative obesity market, the company’s next-gen prospect, the trip…
PipelineSTAT News ↗
A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of t…
PipelineBriefing
The global phase 3 win gives Merck’s sacituzumab tirumotecan fresh momentum across 17 ongoing ADC trials, offe…
PipelinePharmaceutical Technology ↗
48 weeks of Trikafta treatment improved lung capacity and inflammation biomarkers among CF patients.…
PipelineSTAT News ↗
A UCSF team has submitted an application to the FDA seeking approval for a small trial of in utero gene therap…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.